Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. I. The role of glutamate

J Pharmacol Exp Ther. 1995 Oct;275(1):7-13.

Abstract

In this study we compared the effects of two nitrogen monoxide (NO) generators, hydroxylamine and S-nitroso-L-cysteine (NO-CYS), on hippocampal [3H]norepinephrine ([3H]NE) release. A 10-min incubation with hydroxylamine (3-3,000 microM) or NO-CYS (30-10,000 microM) induced a concentration-dependent increase in the basal [3H]NE efflux with EC50 values of approximately 100 microM and 1 mM, respectively. Reduced hemoglobin, a NO scavenger, blocked both hydroxylamine- and NO-CYS-evoked [3H]NE release. Long-term exposure (> or = 25 min) to 100 microM hydroxylamine, or to millimolar concentrations of NO-CYS, evoked a tetrodotoxin-insensitive [3H]NE release. However, a 10-min stimulation with either 100 microM hydroxylamine or 300 microM NO-CYS was sensitive to 0.5 microM tetrodotoxin, a voltage-sensitive sodium channel blocker. This suggested that under these conditions hydroxylamine and NO-CYS induce [3H]NE release indirectly in part, perhaps via releasing an excitatory neurotransmitter. Indeed, kynurenate, a nonselective ionotropic glutamate receptor antagonist, produced an 80% inhibition of the NO generator-evoked [3H]NE release. CGS 19755, a N-methyl-D-aspartate receptor antagonist, had no significant effect, whereas the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/kainate receptor antagonists, CNQX and GYKI 52446, inhibited the hydroxylamine response by 50%. In synaptosomes, a preparation in which synaptic interactions are nonsignificant, NO-CYS induced a dose-dependent release of both [3H]NE and [3H]glutamate. These data suggest that, in hippocampal slices, NO generators evoke [3H]NE release both directly from noradrenergic terminals and indirectly via releasing glutamate.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium / physiology
  • Cyclic GMP / metabolism
  • Cysteine / analogs & derivatives
  • Cysteine / pharmacokinetics
  • Cysteine / pharmacology
  • Cytoplasm / metabolism
  • Glutamic Acid / physiology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism*
  • Hydroxylamine
  • Hydroxylamines / pharmacokinetics
  • Hydroxylamines / pharmacology
  • In Vitro Techniques
  • Male
  • Nitric Oxide / pharmacokinetics
  • Nitric Oxide / pharmacology*
  • Norepinephrine / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / physiology
  • Receptors, Kainic Acid / physiology
  • S-Nitrosothiols*
  • Stimulation, Chemical
  • Tritium
  • Vasodilator Agents / pharmacology

Substances

  • Hydroxylamines
  • Receptors, AMPA
  • Receptors, Kainic Acid
  • S-Nitrosothiols
  • Vasodilator Agents
  • Tritium
  • Hydroxylamine
  • Nitric Oxide
  • Glutamic Acid
  • S-nitrosocysteine
  • Cyclic GMP
  • Cysteine
  • Calcium
  • Norepinephrine